SEARCH

SEARCH BY CITATION

References

  • Ansari NA, Ramesh V & Salotra P (2006) Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis 194: 958965.
  • Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA & Tacchini-Cottier F (2002) The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol 169: 32323241.
  • Bossolasco S, Gaiera G, Olchini D et al. (2003) Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis. J Clin Microbiol 4: 50805084.
  • Bretagne S, Durand R, Olivi M et al. (2001) Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immun 8: 828831.
  • Coste SC, Heldwein KA, Stevens SL, Tobar-Dupres E & Stenzel-Poore MP (2001) IL-1 and TNF down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology 142: 35373545.
  • Dasgupta B, Roychoudhury K, Ganguly S, Akbar MA, Das P & Roy S (2003) Infection of human mononuclear phagocytes and macrophage-like THP1 cells with Leishmania donovani results in modulation of expression of a subset of chemokines and a chemokine receptor. Scand J Immunol 57: 366374.
  • Díaz NL, Arveláez FA, Zerpa O & Tapia FJ (2006) Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis. Clin Exp Dermatol 31: 114117.
  • Dogra J, Aneja N, Lal BB & Mishra SN (1990) Cutaneous leishmaniasis in India: clinical experience with Itraconazole (R51211 Janssen). Int J Dermatol 29: 661662.
  • Harris E, Kropp G, Belli A, Rodriguez B & Agabian N (1998) Single step multiplex PCR assay for characterization of new world Leishmania complexes. J Clin Microbiol 36: 19891995.
  • Heinzel FP, Sadick MD, Mutha SS & Locksley RM (1991) Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. P Natl Acad Sci USA 88: 70117015.
  • Hepburn NC (2001) Management of cutaneous leishmaniasis. Curr Opin Infect Dis 14: 151154.
  • Hepburn NC (2003) Cutaneous leishmaniasis: an overview. J Postgrad Med 49: 5057.
  • Howard JG, Hale C & Chan-Liew WL (1980) Immunological regulation of cutaneous experimental leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol 2: 303314.
  • Jauregui LH, Higgins J, Zarlenga D, Dubey JP & Luney JK (2001) Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues. J Clin Microbiol 39: 20652071.
  • Kébaïer C, Louzir H, Chenik M, Ben Salah A & Dellagi K (2001) Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response. Infect Immun 69: 49064915.
  • Kochar DK, Aseri S, Sharma BV et al. (2000) The role of rifampicin in the management of cutaneous leishmaniasis. Q J Med 93: 733737.
  • Kumar R, Bumb RA, Ansari NA, Mehta RD & Salotra P (2007) Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunological tools. Am J Trop Med Hyg 76: 896901.
  • Launois P, Maillard I, Pingel S, Swihart KG, Xénarios I, Acha-Orbea H, Diggelmann H, Locksley RM, MacDonald HR & Louis JA (1997) IL-4 rapidly produced by V beta 4V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6: 541549.
  • Launois P, Conceicao-Silva F, Himmerlich H, Parra-Lopez C, Tacchini-Cottier F & Louis JA (1998) Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major. Parasite Immunol 20: 223230.
  • Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL & Sadick MD (1991) Induction of Th1 and Th2 CD41 subsets during murine Leishmania major infection. Res Immunol 142: 2832.
  • Louzir H, Melby PC, Salah AB et al. (1998) Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to L. major. J Infect Dis 177: 16871695.
  • Mary C, Faraut F, Lascombe L & Dumon H (2004) Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42: 52495255.
  • Meide VW, Guerra J, Schoone G et al. (2008) Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites. J Clin Microbiol 46: 7378.
  • Morris L, Troutt AB, McLeod KS, Kelso A, Handman E & Aebischer T (1993) Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun 61: 34593465.
  • Nicolas L, Prina E, Lang T & Milon G (2002) Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J Clin Microbiol 40: 16661669.
  • Nogueira MF, Goto H, Sotto MN & Cucé LC (2008) Cytokine profile in montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis. Rev Inst Med Trop Sao Paulo 50: 333337.
  • Perandin F, Manca N, Calderaro A et al. (2004) Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol 42: 12141219.
  • Piron M, Fisa R, Casamitjana N et al. (2007) Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195200.
  • Rolao S, Cortes S, Rodrigues OR & Campino L (2004) Quantification of Leishmania infantum parasites in tissue biopsies by real-time polymerase chain reaction-enzyme-linked immunosorbant assay. J Parasitol 90: 11501154.
  • Salman SM, Rubeiz NG & Kibbi AG (1999) Cutaneous leishmaniasis: clinical features and diagnosis. Clin Dermatol 17: 291296.
  • Salotra P, Sreenivas G, Pogue GP et al. (2001) Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post kala-azar dermal leishmaniasis. J Clin Microbiol 39: 849854.
  • Satoskar A, Bluethmann H & Alexander J (1995) Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun 63: 48944899.
  • Schallig HDFH & Oskam L (2002) Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification. Trop Med Int Health 7: 641651.
  • Schonian G, Schnur L, El Fari M et al. (2001) Genetic heterogeneity in the species Leishmania tropica revealed by different PCR-based methods. T R Soc Trop Med H 95: 217224.
  • Schulz A, Mellenthin K, Schonian G, Fleischer B & Drosten C (2003) Detection, differentiation, and quantitation of pathogenic Leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41: 15291535.
  • Schwenkenbecher JM, Wirth T, Schnur LF et al. (2006) Microsatellite analysis reveals genetic structure of Leishmania tropica. Int J Parasitol 36: 237246.
  • Sharma MID, Suri JC, Kalra NL, Mohan K & Swami PN (1973) Epidemiological and entomological features of an outbreak of cutaneous leishmaniasis in Bikaner, Rajasthan, during 1971. J Communicable Dis 5: 5472.
  • Sharma NL, Mahajan VK, Kanga A et al. (2005) Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in Himachal Pradesh, India. Am J Trop Med Hyg 72: 819824.
  • Wortman G, Hochberg L, Houng HH et al. (2007) Rapid identification of Leishmania complexes by a real-time PCR assay. Am J Trop Med Hyg 73: 9991004.